1
|
Abramovits W: Atopic dermatitis. J Am Acad
Dermatol. 53(Suppl 1): S86–S93. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Leung DY, Boguniewicz M, Howell MD, Nomura
I and Hamid QA: New insights into atopic dermatitis. J Clin Invest.
113:651–657. 2004. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Shimizu N, Dairiki K, Ogawa S and Kaneko
T: Dietary whey protein hydrolysate suppresses development of
atopic dermatitis-like skin lesions induced by mite antigen in
NC/Nga mice. Allergol Int. 55:185–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kang JS, Lee K, Han SB, et al: Induction
of atopic eczema/dermatitis syndrome-like skin lesions by repeated
topical application of a crude extract of Dermatophagoides
pteronyssinus in NC/Nga mice. Int Immunopharmacol. 6:1616–1622.
2006. View Article : Google Scholar : PubMed/NCBI
|
5
|
Grabbe S and Schwarz T: Immunoregulatory
mechanisms involved in elicitation of allergic contact
hypersensitivity. Immunol Today. 19:37–44. 1998. View Article : Google Scholar : PubMed/NCBI
|
6
|
Bardana EJ Jr: Immunoglobulin E-(IgE) and
non-IgE-mediated reactions in the pathogenesis of atopic
eczema/dermatitis syndrome (AEDS). Allergy. 78:25–29. 2004.
View Article : Google Scholar
|
7
|
Lee SO, Lou W, Nadiminty N, Lin X and Gao
AC: Requirement for NF-(kappa)B in interleukin-4-induced androgen
receptor activation in prostate cancer cells. Prostate. 64:160–167.
2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Georas SN, Guo J, De Fanis U and Casolaro
V: T-helper cell type-2 regulation in allergic disease. Eur Respir
J. 26:1119–1137. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Garrigue JL, Nicolas JF, Fraginals R,
Benezra C, Bour H and Schmitt D: Optimization of the mouse ear
swelling test for in vivo and in vitro studies of weak contact
sensitizers. Contact Dermatitis. 30:231–237. 1994. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gong JH, Shin D, Han SY, et al: Blockade
of airway inflammation by kaempferol via disturbing Tyk-STAT
signaling in airway epithelial cells and in asthmatic mice. Evid
Based Complement Alternat Med. 2013:2507252013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Dharmage SC, Lowe AJ, Matheson MC, Burgess
JA, Allen KJ and Abramson MJ: Atopic dermatitis and the atopic
march revisited. Allergy. 69:17–27. 2014. View Article : Google Scholar
|
12
|
Joo SS, Yoo YM, Ko SH, et al: Effects of
essential oil from Chamaecypris obtusa on the development of atopic
dermatitis-like skin lesions and the suppression of Th cytokines. J
Dermatol Sci. 60:122–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Park D, Jeon JH, Kwon SC, et al:
Antioxidative activities of white rose flower extract and
pharmaceutical advantages of its hexane fraction via free radical
scavenging effects. Biochem Cell Biol. 87:943–952. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Lehmann I, Rehwagen M, Diez U, et al:
Enhanced in vivo IgE production and T cell polarization toward the
type 2 phenotype in association with indoor exposure to VOC:
results of the LARS study. Int J Hyg Environ Health. 204:211–221.
2001. View Article : Google Scholar
|
15
|
Diez U, Kroessner T, Rehwagen M, et al:
Effects of indoor painting and smoking on airway symptoms in atopy
risk children in the first year of life results of the LARS-study.
(Leipzig allergy high-risk children study). Int J Hyg Environ
Health. 203:23–28. 2000. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wieslander G, Norbäck D, Björnsson E,
Janson C and Boman G: Asthma and the indoor environment: the
significance of emission of formaldehyde and volatile organic
compounds from newly painted indoor surfaces. Int Arch Occup
Environ Health. 69:115–124. 1997. View Article : Google Scholar : PubMed/NCBI
|
17
|
Boguniewicz M and Leung DY: Atopic
dermatitis: a disease of altered skin barrier and immune
dysregulation. Immunol Rev. 242:233–246. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
de Bruin-Weller MS and Bruijnzeel-Koomen
CA: Topical immunomodulators, such as tacrolimus and pimecrolimus,
in the treatment of atopic dermatitis. Ned Tijdschr Geneeskd.
149:1096–1100. 2005.In Dutch. PubMed/NCBI
|
19
|
Kawai M, Hirano T, Higa S, et al:
Flavonoids and related compounds as anti-allergic substances.
Allergol Int. 56:113–123. 2007. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tan HY, Zhang AL, Chen D, Xue CC and Lenon
GB: Chinese herbal medicine for atopic dermatitis: a systematic
review. J Am Acad Dermatol. 69:295–304. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Heinzel FP, Sadick MD, Holaday BJ, Coffman
RL and Locksley RM: Reciprocal expression of interferon gamma or
interleukin 4 during the resolution or progression of murine
leishmaniasis. Evidence for expansion of distinct helper T cell
subsets. J Exp Med. 169:59–72. 1989. View Article : Google Scholar : PubMed/NCBI
|
22
|
Surh YJ, Na HK, Lee JY and Keum YS:
Molecular mechanisms underlying anti-tumor promoting activities of
heat-processed Panax ginseng CA Meyer. J Korean Med Sci.
16:S38–S41. 2001. View Article : Google Scholar
|
23
|
Jang HW, Ka MH and Lee KG: Antioxidant
activity and characterization of volatile extracts of Capsicum
annuum L. and Allium spp. Flavour Fragr J. 23:178–184. 2008.
View Article : Google Scholar
|
24
|
Hong EJ, Na KJ, Choi IG, Choi KC and Jeung
EB: Antibacterial and antifungal effects of essential oils from
coniferous trees. Biol Pharm Bull. 27:863–866. 2004. View Article : Google Scholar : PubMed/NCBI
|
25
|
Lee HO, Baek SH and Han DM: Antimicrobial
effects of Chamaecypris obutusa essential oil. Korean J Appl
Microbiol Biotechnol. 29:253–257. 2001.
|
26
|
Thaçi D: Long term management of childhood
atopic dermatitis with calcineurin inhibitors. Hautarzt.
54:418–423. 2003.In German.
|
27
|
Vender RB: Alternative treatments for
atopic dermatitis: a selected review. Skin Therapy Lett. 7:1–5.
2002.PubMed/NCBI
|
28
|
Wang W, Zhou Q, Liu L and Zou K:
Anti-allergic activity of emodin on IgE-mediated activation in
RBL-2H3 cells. Pharmacol Rep. 64:1216–1222. 2012. View Article : Google Scholar : PubMed/NCBI
|